Entero Healthcare Solutions began in 2018 with the aim of providing an organised and integrated healthcare products distribution system. It has expanded to include retail pharmacies, hospitals, medical devices and consumables, comprehensive commercial solutions, supply chain and distribution, and technology services to its clients. With more than 3500 hospital clients, it has established the biggest network of hospital clients among Indian distributors of pharmaceutical products. Additionally, Entero serves over 86,300 retail customers and more than 2000 pharma and healthcare product manufacturers. The company is present in 540 districts in 39 cities like Mumbai, Delhi, Jaipur, and Kolkata, with 79 physical warehouses across India.
PARAMETERS | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenue (INR Cr) | 3994 20.1% | 3325 30.1% | 2557 39.7% | 1831 - |
Net Operating Income (INR Cr) | 3922 18.85% | 3300 30.85% | 2522 41.71% | 1780 0.00% |
Profit (INR Cr) | 39 - | -12 - | -30 - | -16 - |
Assets (INR Cr) | 1986 90.9% | 1041 12.9% | 922 33.1% | 693 - |
Net Worth (INR Cr) | 1638 2488.2% | -69 -18.4% | -58 -82.5% | -32 0.0% |
Employee Cost (INR Cr) | 151 18.0% | 128 11.6% | 115 51.2% | 76 - |
Interest Cost (INR Cr) | 66 | 49 | 29 | 20 |
Cash & Bank Balance (INR Cr) | 893 | 107 | 105 | 83 |
Total Debt (INR Cr) | 338 | 438 | 355 | 203 |
PARAMETERS | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Profit As % Of Revenues | 1.0% | - | - | - |
Profit As % Of Assets | 2.0% | - | - | - |
Profit As % Of Networth | 2.4% | - | - | - |
Interest Cost to EBITDA % | 58.7% | 76.5% | 118.6% | 93.0% |
Debt to Equity Ratio | 0.21 | - | - | - |
RONW | 5.0% | - | - | - |
ROCE | 6.6% | 0.0% | 0.0% | 0.0% |